When do we return to work? The market reaction? The drug pipeline? Chief Cross-Asset Strategist Andrew Sheets and Head Biotech Equity Analyst Matthew Harrison continue their discussion on the impact of the Covid-19 pandemic.
MORGANSTANLEY.COM
Can $2 Trillion Flatten the Unemployment Curve? | Morgan Stanley
Sharp rally in tech/internet stocks sends markets higher Tuesday with NASDAQ 100 back to flat on the year. Read more in the 1% Move report:
MORGANSTANLEY.COM
S&P Market 1 Percent Move Report from Morgan Stanley | Morgan Stanley
If there is one lesson to be learned from the financial repression era it's that when risk premium appears, investors may want to make moves before it evaporates.
MORGANSTANLEY.COM
U.S. Equities: Is the Worst Behind Us? | Morgan Stanley
S&P 500 posts modest decline following last week's surge as earnings season set to begin; Read more in the 1% Move report:
MORGANSTANLEY.COM
S and P Market 1 Percent Move Report from Morgan Stanley | Morgan Stanley
How do you track a virus, a global economy and a road to recovery? On this special episode, an engaging conversation with our Chief Cross-Asset Strategist and Head Biotech Equity Analyst.
MORGANSTANLEY.COM
Can $2 Trillion Flatten the Unemployment Curve? | Morgan Stanley
Market volatility can be unsettling, but it shouldn't force you to overreact. We can help you analyze the risk in your portfolio and model changes to help keep your goals on track. Learn more.
PLAYERS.BRIGHTCOVE.NET
players.brightcove.net
